Health Canada drug identification number

DIN 00769541 — SOLYSTAT 250 MG

SOLYSTAT is a suspension of Sodium Polystyrene Sulfonate marketed by PENDOPHARM DIVISION OF PHARMASCIENCE INC. The full Sodium Polystyrene Sulfonate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00769541
Brand name
SOLYSTAT
Strength
250 MG
Dosage form
SUSPENSION
Route
ORAL
Manufacturer
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Health Canada status
MARKETED
Drug class
Potassium-binding cation-exchange resin

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Sodium Polystyrene Sulfonate products

DINBrandStrengthFormManufacturerStatus
02497557 JAMP SODIUM POLYSTYRENE SULFONATE 1 G POWDER FOR SUSPENSION JAMP PHARMA CORPORATION MARKETED
02026961 KAYEXALATE 1 G POWDER FOR SUSPENSION SANOFI-AVENTIS CANADA INC MARKETED
02473941 ODAN-SODIUM POLYSTYRENE SULFONATE 1 G POWDER FOR SUSPENSION ODAN LABORATORIESLTD MARKETED
02473968 ODAN-SODIUM POLYSTYRENE SULFONATE 250 MG SUSPENSION ODAN LABORATORIESLTD MARKETED
00755338 SOLYSTAT 1 G POWDER FOR SUSPENSION PENDOPHARM DIVISION OF PHARMASCIENCE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.